Samedan

Welcome to the January/February edition of Pharmafocus! This edition includes the biggest news from new drug approvals in the US, EU, and elsewhere, to the FDA's new regulations around medication abortions, as well as an article from the expert panel of the new Let's Talk Prostate Cancer initiative. 

Welcome to the January/February edition of Pharmafocus! New drug approvals in the US, EU, and elsewhere, the FDA's new regulations around medication abortions, as well as views from the expert panel of the new Let's Talk Prostate Cancer initiative. 

Pharmafocus - January 2023

trade-gothic-lt

trade-gothic-lt-bold

SAMEDAN